Stifel Financial
CMPX icon

Stifel Financial’s Compass Therapeutics CMPX Stock Holding History

Stifel Financial’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145K Buy
27,497
+3,524
+15% +$20.3K ﹤0.01% 3496
2025
Q4 		$129K Buy
+23,973
New +$111K ﹤0.01% 3458
2023
Q4 		– Sell
-15,000
Closed -$29.6K – 3341
2023
Q3 		$29.6K Hold
15,000
– – ﹤0.01% 3222
2023
Q2 		$47.7K Buy
+15,000
New +$47.1K ﹤0.01% 3243

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Stifel Financial's CMPX Position: Q1 2026 in Review

Stifel Financial increased its Compass Therapeutics (CMPX) stake by 15% in Q1 2026, buying an estimated $20.3K and bringing the position to 27,497 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #3496.

Stifel Financial first reported a position in CMPX in Q2 2023 and has held it in 4 quarters since. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Stifel Financial held 27,497 shares of Compass Therapeutics worth $145K as of Q1 2026.
  • Stifel Financial bought 3,524 Compass Therapeutics shares in Q1 2026, an estimated $20.3K.
  • Compass Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3496 holding.
  • Stifel Financial first reported a position in Compass Therapeutics in Q2 2023 and has held it in 4 quarters since.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.